State of the Art ReviewCancer

On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation

See allHide authors and affiliations

Science Translational Medicine  25 Mar 2015:
Vol. 7, Issue 280, pp. 280sr1
DOI: 10.1126/scitranslmed.3010274

Article Information

vol. 7 no. 280 280sr1

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication January 26, 2015
  • Accepted for publication March 6, 2015

Author Information

  1. Alexander M. Lesokhin1,2,*,
  2. Margaret K. Callahan1,2,
  3. Michael A. Postow1,2 and
  4. Jedd D. Wolchok1,2
  1. 1Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  2. 2Weill Cornell Medical College, New York, NY 10065, USA.
  1. *Corresponding author. E-mail: lesokhia{at}mskcc.org

Altmetric

Article usage

Article usage: March 2015 to July 2019

AbstractFullPdf
Mar 201595539121215
Apr 20152844377582
May 201592288181
Jun 2015565106140
Jul 201538410692
Aug 20153689793
Sep 20152895790
Oct 201530410586
Nov 20152258085
Dec 20151906044
Jan 201644268172
Feb 20162512760
Mar 20163762890
Apr 20163112386
May 20162522847
Jun 20162092659
Jul 20161612746
Aug 20161872331
Sep 20161681637
Oct 20161591732
Nov 2016121825
Dec 20161652139
Jan 20171651234
Feb 20171111332
Mar 20171602336
Apr 20171451628
May 20171161624
Jun 20171141730
Jul 2017951024
Aug 20171241125
Sep 2017951220
Oct 2017105512
Nov 20172202340
Dec 20171091121
Jan 20181061320
Feb 20181081625
Mar 2018801613
Apr 20181311822
May 20181071214
Jun 2018109916
Jul 201872149
Aug 2018561512
Sep 2018902123
Oct 2018781513
Nov 2018982519
Dec 2018871311
Jan 20195055
Feb 2019821613
Mar 201951139
Apr 2019331311
May 2019401611
Jun 201925107
Jul 20191170